Skip to content

Impact of the BB Box System on Postpartum Maternal Anxiety, Post Traumatic Stress and Mother-child Relationships

Pilot Study Evaluating the Impact of the BB Box System on Postpartum Maternal Anxiety, Post Traumatic Stress and the Establishment of a Mother-child Relationship in the Context of a Premature Birth

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01566058
Acronym
BBBox
Enrollment
59
Registered
2012-03-29
Start date
2013-01-31
Completion date
2015-04-30
Last updated
2015-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Stress Disorders, Post-Traumatic

Keywords

Post partum, mother-child relationships

Brief summary

The main objective of this study is to compare the degree of maternal anxiety at Day 3 postpartum in mothers who did or did not have access to a video communication system (BB-Box system) from the time of initial separation with their baby.

Detailed description

The secondary objectives of the study are to compare the following between the two arms of the study: A. The degree of postpartum maternal anxiety at day 1, day 7 and at hospital discharge. Anxiety will be compared point by point but also via kinetics. B. The incidence maternal post traumatic stress disorder at 6 and 12 months. C. The incidence of mother-child relationship disorders at 6 and 12 months. D. Infant vital signs during the hospital stay.

Interventions

DEVICEBB Box available

The BB Box video system is provided to the mother during the hospitalisation of her premature baby.

OTHERNo BB Box

The BB Box video system is not provided to the mother during the hospitalisation of her premature baby.

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The patient must have given his/her informed and signed consent * The patient must be insured or beneficiary of a health insurance plan * The patient is available for 12 months of follow up * The patient has given birth this day to a premature child (\< 36 weeks of gestation and/or \< 2 kg birthweight) * Separation of child and mother since birth

Exclusion criteria

* The patient or baby is participating in another study, excepting the studies OASIS or PROM8736 * The patient or baby is in an exclusion period determined by a previous study * The patient is under judicial protection, under tutorship or curatorship * The patient or father refuses to sign the consent * It is impossible to correctly inform the patient * Preexisting maternal psychiatric pathology * Major or lethal poly-malformation syndrome * Severe pathologies that threaten child survival: pulmonary hypertension, septic shock, anoxic-ischemic brain * Any emergency situation preventing patient involvement * Mother and/or child not hospitalized at the Nîmes University Hospital * Death of the patient or child during the study

Design outcomes

Primary

MeasureTime frameDescription
Questionnaire HADSDay 3 post-partumScore ranging from 0 - 21

Secondary

MeasureTime frameDescription
Questionnaire HADSbaseline; day 0score ranging from 0 to 21
Questionnaire PPQ (post traumatic stress disorder)6 months post partumscore ranging from 0 to 14
Massie Campbell scale for mother-child relationshipsDay of hospital discharge for the baby (expected average of 4 weeks)
Number of infant cardiovascular eventsbase line to day of hospital discharge for the baby (expected average of 4 weeks)includes bradycardia \< 100/min and O2 saturation \< 60%

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026